Extra cash could be coming to ten as it close to selling Eyecorp for more that $125M. Recent $200M capital rasing that extra $350M if sale going ahead, almost wiping out it debt.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025